Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +55.5% | +52.0% | 2 / 3 | +20.3% | +2.09 pp | +1.72 pp | +12.4% | 0.00 | 10.61 | 2.835 | +20,3% | 240 | +50,9% | 10.61 | 20.57 | −48,4% |
| Pts | 8 | 12 | 8 | 12 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 27.100 (close price on 2026-10-19)EPS (TTM): 2.555
Financial charts
1.Revenue & growth
VND bn2.835Q2/26
1.Revenue & growth
VND bn2.835Q2/26
2.Profit & growth
VND bn222Q2/26
3.Profit mix (Penman)
VND bn773Q2/26
4.Margins & cost structure
%29.2%Q2/26
5.Returns & cash cycle
% · days76.9%Q2/26
6.Earnings quality & cash
VND bn581Q2/26
7.Asset structure
VND bn8.027Q2/26
8.Funding & debt health
VND bn · times8.027Q2/26
9.Revenue backlog
VND bn38,9Q2/26
10.Valuation
times · %10,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %959Q2/26
Adjusted EPS growth, latest quarter
55.5%
Average adjusted EPS growth, 3 quarters
52.0%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26